Hormone Receptor-Positive Metastatic Breast Cancer — An Interview with Dr Adam M Brufsky on the Impact of Biomarkers and Existing Comorbidities on the Selection of First-Line Therapy

Research To Practice | Oncology Videos · Apr 25, 2025 · 52m

Featuring an interview with Dr Adam M Brufsky, including the following topics:

Case: A woman in her early 50s with ER-positive, HER2-low de novo metastatic breast cancer (0:00)

Case: A woman in her late 70s with ER-positive, HER2-low metastatic breast cancer after 5 years of an adjuvant aromatase inhibitor (6:52)

Clinical Investigator Survey Results (10:05)

CME information and select publications